IV 
117TH CONGRESS 
2D SESSION 
H. RES. 1285 
Requesting the President to transmit certain information to the House of 
Representatives relating to a waiver of intellectual property commitments 
under the World Trade Organization Agreement on Trade-Related As-
pects of Intellectual Property Rights. 
IN THE HOUSE OF REPRESENTATIVES 
JULY 26, 2022 
Mr. SMITH of Nebraska (for himself and Mr. BRADY) submitted the following 
resolution; which was referred to the Committee on Ways and Means 
RESOLUTION 
Requesting the President to transmit certain information 
to the House of Representatives relating to a waiver 
of intellectual property commitments under the World 
Trade Organization Agreement on Trade-Related Aspects 
of Intellectual Property Rights. 
Resolved, That the President is requested to transmit 
1
to the House of Representatives, not later than 14 days 
2
after the date of the adoption of this resolution, copies 
3
of all documents, memoranda, advisory legal opinions, 
4
notes from meetings, audio recordings, records (including 
5
telephone and electronic mail records), correspondence, or 
6
other communications, or any portion of any such commu-
7
VerDate Sep 11 2014 
05:30 Jul 27, 2022
Jkt 029200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\HR1285.IH
HR1285
kjohnson on DSK79L0C42PROD with BILLS
2 
•HRES 1285 IH 
nications, to the extent that any such one or more items 
1
are within the possession of the President, that dem-
2
onstrate— 
3
(1) the waiver of intellectual property commit-
4
ments under the World Trade Organization Agree-
5
ment on Trade-Related Aspects of Intellectual Prop-
6
erty Rights (in this resolution referred to as 
7
‘‘TRIPS waiver’’) that was agreed to on June 17, 
8
2022, will increase global supply and delivery of 
9
COVID–19 vaccines; 
10
(2) the extent to which COVID–19 vaccines 
11
have been destroyed due to their expiration and the 
12
period during which this occurred; 
13
(3) the proposed expansion of the TRIPS waiv-
14
er 
to 
cover 
intellectual 
property 
related 
to 
15
diagnostics and therapeutics (in this resolution re-
16
ferred to as the ‘‘proposed TRIPS waiver expan-
17
sion’’) will increase global supply and delivery of 
18
COVID–19 diagnostics or therapeutics; 
19
(4) the TRIPS waiver or the proposed TRIPS 
20
waiver expansion will accelerate the end of the 
21
COVID–19 pandemic; and 
22
(5) the People’s Republic of China will not ob-
23
tain access to patents or other intellectual property 
24
related to COVID–19 vaccines, diagnostics, or thera-
25
VerDate Sep 11 2014 
05:30 Jul 27, 2022
Jkt 029200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\HR1285.IH
HR1285
kjohnson on DSK79L0C42PROD with BILLS
3 
•HRES 1285 IH 
peutics, even if China is expressly excluded from the 
1
TRIPS waiver or the proposed TRIPS waiver expan-
2
sion. 
3
Æ 
VerDate Sep 11 2014 
05:30 Jul 27, 2022
Jkt 029200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6301
E:\BILLS\HR1285.IH
HR1285
kjohnson on DSK79L0C42PROD with BILLS
